Centessa Pharmaceuticals plc
CNTADelisted Jun 24, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847903
Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding Centessa Pharmaceuticals plc changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 80 | 1 | 103 | +24 |
| Shares | 86.5M | 464.6K | 108.6M | +22.5M (+26.2%) |
| Value | $781.2M | $4.20M | $1.74B | +$960.5M (+123.6%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (32)
Institutions that held Centessa Pharmaceuticals plc at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (8)
Institutions that held Centessa Pharmaceuticals plc at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Artal Group S.A. | 2,112,500 | $19.1M |
| ExodusPoint Capital Management, LP | 87,210 | $788.0K |
| Vestcor Inc | 20,300 | $183.0K |
| Schonfeld Strategic Advisors LLC | 12,300 | $111.1K |
| Quarry LP | 9,608 | $86.8K |
| Wells Fargo & Company | 520 | $4.70K |
| Advisor Group Holdings, Inc. | 407 | $3.67K |
| Spire Wealth Management | 70 | $632 |
Not filed for Q3 2024 yet (1)
Institutions that held Centessa Pharmaceuticals plc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 464,622 | $4.20M |